PXS 0.00% 8.5¢ pharmaxis ltd

ASX listed IMMURON LIMITED recently announced Phase 2 trail...

  1. 3,534 Posts.
    lightbulb Created with Sketch. 64
    ASX listed IMMURON LIMITED recently announced Phase 2 trail success on its NASH drug IMM-124E.
    With only 1 meaningful drug on trail and merely 500k cash left, IMC' market cap is about half of Pharmaxis, which has far more bigger drug pipeline and tons of cash.

    People may start to realise where the value is...
 
watchlist Created with Sketch. Add PXS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.